The drug-interaction studies have not been performed with Dymista Nasal Spray. The coadministration with strong cytochrome P-450 (CYP) 3A4 inhibitors (e.g., ritonavir, ketoconazole) should be concerned because they affect to plasma concentration of fluticasone propionate.